Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2-4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER).
Stewart J TepperJessica AilaniJanet H FordRussell M NicholsLily Q LiPhebe KemmerAustin L HandAntje Tockhorn-HeidenreichPublished in: Clinical drug investigation (2022)
NCT03559257, registration date: 6 June, 2018.